 | • レポートコード：MRC2Q12-00652 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、114ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：化学&材料 |
| Single User | ￥735,000 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,470,000 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、(-)-トランス-カリオフィレンのグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 (-)-トランス-カリオフィレンのアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 (-)-トランス-カリオフィレンの中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 (-)-トランス-カリオフィレンのヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までの(-)-トランス-カリオフィレンの生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の(-)-トランス-カリオフィレンの売上および2028年までの予測に焦点を当てています。 (-)-トランス-カリオフィレンのグローバル主要企業には、Sigma-Aldrich、MP Biomedicals、Santa Cruz Biotechnology、BioCrick、Supelco、Toronto Research Chemicals、National Analytical Corporation、ChemFaces、Extrasynthese、Purisys、Axios、Wen Xi Pharmaなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 (-)-トランス-カリオフィレン市場は、タイプとアプリケーションによって区分されます。世界の(-)-トランス-カリオフィレン市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 98%以上、98.5%以上、その他 【アプリケーション別セグメント】 実験研究、生物医学、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - (-)-トランス-カリオフィレン製品概要 - タイプ別市場（98%以上、98.5%以上、その他） - アプリケーション別市場（実験研究、生物医学、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の(-)-トランス-カリオフィレン販売量予測2017-2028 - 世界の(-)-トランス-カリオフィレン売上予測2017-2028 - (-)-トランス-カリオフィレンの地域別販売量 - (-)-トランス-カリオフィレンの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別(-)-トランス-カリオフィレン販売量 - 主要メーカー別(-)-トランス-カリオフィレン売上 - 主要メーカー別(-)-トランス-カリオフィレン価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（98%以上、98.5%以上、その他） - (-)-トランス-カリオフィレンのタイプ別販売量 - (-)-トランス-カリオフィレンのタイプ別売上 - (-)-トランス-カリオフィレンのタイプ別価格 ・アプリケーション別市場規模（実験研究、生物医学、その他） - (-)-トランス-カリオフィレンのアプリケーション別販売量 - (-)-トランス-カリオフィレンのアプリケーション別売上 - (-)-トランス-カリオフィレンのアプリケーション別価格 ・北米市場 - 北米の(-)-トランス-カリオフィレン市場規模（タイプ別、アプリケーション別） - 主要国別の(-)-トランス-カリオフィレン市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの(-)-トランス-カリオフィレン市場規模（タイプ別、アプリケーション別） - 主要国別の(-)-トランス-カリオフィレン市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の(-)-トランス-カリオフィレン市場規模（タイプ別、アプリケーション別） - 主要国別の(-)-トランス-カリオフィレン市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の(-)-トランス-カリオフィレン市場規模（タイプ別、アプリケーション別） - 主要国別の(-)-トランス-カリオフィレン市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの(-)-トランス-カリオフィレン市場規模（タイプ別、アプリケーション別） - 主要国別の(-)-トランス-カリオフィレン市場規模（トルコ、サウジアラビア） ・企業情報 Sigma-Aldrich、MP Biomedicals、Santa Cruz Biotechnology、BioCrick、Supelco、Toronto Research Chemicals、National Analytical Corporation、ChemFaces、Extrasynthese、Purisys、Axios、Wen Xi Pharma ・産業チェーン及び販売チャネル分析 - (-)-トランス-カリオフィレンの産業チェーン分析 - (-)-トランス-カリオフィレンの原材料 - (-)-トランス-カリオフィレンの生産プロセス - (-)-トランス-カリオフィレンの販売及びマーケティング - (-)-トランス-カリオフィレンの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - (-)-トランス-カリオフィレンの産業動向 - (-)-トランス-カリオフィレンのマーケットドライバー - (-)-トランス-カリオフィレンの課題 - (-)-トランス-カリオフィレンの阻害要因 ・主な調査結果 |
(-)-Trans-Caryophyllene, a sesquiterpene, is the main constituent of the essential oils of Mentha longifolia and Commiphora gileadensis. It has anti-inflammatory, local anesthetic and antifungal properties. (-)-Trans-Caryophyllene also exhibited potent cytotoxic activity.Trans caryophyllene is another sesquiterpene that often appears in conjunction with beta-caryophyllene. It has similar medicinal properties to other terpenes but does not activate the endocannabinoid system. Peppery, spicy, sweet, or woodsy. Sesquiterpene that results from the oxidation of beta-caryophyllene. colorless to light yellow oily liquid. Molecular weight 204.36, boiling point 256 ℃(1.013 ×los Pa),118~121 ℃(1333Pa), relative density 0.9075, refractive index 1.5030. Insoluble in water, soluble in ethanol, with light clove odor. Natural products are found in clove oil, clove stem oil, Ceylon cinnamon oil, cinnamon leaf oil, lavender oil, thyme oil, pepper oil, pepper oil and other essential oils.
Market Analysis and Insights: Global (-)-Trans-Caryophyllene Market
Due to the COVID-19 pandemic, the global (-)-Trans-Caryophyllene market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, More Than 98% accounting for % of the (-)-Trans-Caryophyllene global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Experimental Research segment is altered to an % CAGR throughout this forecast period.
China (-)-Trans-Caryophyllene market size is valued at US$ million in 2021, while the US and Europe (-)-Trans-Caryophyllene are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe (-)-Trans-Caryophyllene landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of (-)-Trans-Caryophyllene include Sigma-Aldrich, MP Biomedicals, Santa Cruz Biotechnology, BioCrick, Supelco, Toronto Research Chemicals, National Analytical Corporation, ChemFaces and Extrasynthese, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
In terms of production side, this report researches the (-)-Trans-Caryophyllene capacity, production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of (-)-Trans-Caryophyllene by region (region level and country level), by company, by Type and by Application. from 2017 to 2022 and forecast to 2028.
Global (-)-Trans-Caryophyllene Scope and Segment
(-)-Trans-Caryophyllene market is segmented by Type and by Application. Players, stakeholders, and other participants in the global (-)-Trans-Caryophyllene market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
More Than 98%
More Than 98.5%
Others
Segment by Application
Experimental Research
Biomedicine
Others
By Company
Sigma-Aldrich
MP Biomedicals
Santa Cruz Biotechnology
BioCrick
Supelco
Toronto Research Chemicals
National Analytical Corporation
ChemFaces
Extrasynthese
Purisys
Axios
Wen Xi Pharma
Production by Region
North America
Europe
China
Japan
India
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
1 Study Coverage
1.1 (-)-Trans-Caryophyllene Product Introduction
1.2 Market by Type
1.2.1 Global (-)-Trans-Caryophyllene Market Size by Type, 2017 VS 2021 VS 2028
1.2.2 More Than 98%
1.2.3 More Than 98.5%
1.2.4 Others
1.3 Market by Application
1.3.1 Global (-)-Trans-Caryophyllene Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Experimental Research
1.3.3 Biomedicine
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global (-)-Trans-Caryophyllene Production
2.1 Global (-)-Trans-Caryophyllene Production Capacity (2017-2028)
2.2 Global (-)-Trans-Caryophyllene Production by Region: 2017 VS 2021 VS 2028
2.3 Global (-)-Trans-Caryophyllene Production by Region
2.3.1 Global (-)-Trans-Caryophyllene Historic Production by Region (2017-2022)
2.3.2 Global (-)-Trans-Caryophyllene Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
2.8 India
3 Global (-)-Trans-Caryophyllene Sales in Volume & Value Estimates and Forecasts
3.1 Global (-)-Trans-Caryophyllene Sales Estimates and Forecasts 2017-2028
3.2 Global (-)-Trans-Caryophyllene Revenue Estimates and Forecasts 2017-2028
3.3 Global (-)-Trans-Caryophyllene Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global (-)-Trans-Caryophyllene Sales by Region
3.4.1 Global (-)-Trans-Caryophyllene Sales by Region (2017-2022)
3.4.2 Global Sales (-)-Trans-Caryophyllene by Region (2023-2028)
3.5 Global (-)-Trans-Caryophyllene Revenue by Region
3.5.1 Global (-)-Trans-Caryophyllene Revenue by Region (2017-2022)
3.5.2 Global (-)-Trans-Caryophyllene Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global (-)-Trans-Caryophyllene Production Capacity by Manufacturers
4.2 Global (-)-Trans-Caryophyllene Sales by Manufacturers
4.2.1 Global (-)-Trans-Caryophyllene Sales by Manufacturers (2017-2022)
4.2.2 Global (-)-Trans-Caryophyllene Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of (-)-Trans-Caryophyllene in 2021
4.3 Global (-)-Trans-Caryophyllene Revenue by Manufacturers
4.3.1 Global (-)-Trans-Caryophyllene Revenue by Manufacturers (2017-2022)
4.3.2 Global (-)-Trans-Caryophyllene Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by (-)-Trans-Caryophyllene Revenue in 2021
4.4 Global (-)-Trans-Caryophyllene Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global (-)-Trans-Caryophyllene Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global (-)-Trans-Caryophyllene Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global (-)-Trans-Caryophyllene Sales by Type
5.1.1 Global (-)-Trans-Caryophyllene Historical Sales by Type (2017-2022)
5.1.2 Global (-)-Trans-Caryophyllene Forecasted Sales by Type (2023-2028)
5.1.3 Global (-)-Trans-Caryophyllene Sales Market Share by Type (2017-2028)
5.2 Global (-)-Trans-Caryophyllene Revenue by Type
5.2.1 Global (-)-Trans-Caryophyllene Historical Revenue by Type (2017-2022)
5.2.2 Global (-)-Trans-Caryophyllene Forecasted Revenue by Type (2023-2028)
5.2.3 Global (-)-Trans-Caryophyllene Revenue Market Share by Type (2017-2028)
5.3 Global (-)-Trans-Caryophyllene Price by Type
5.3.1 Global (-)-Trans-Caryophyllene Price by Type (2017-2022)
5.3.2 Global (-)-Trans-Caryophyllene Price Forecast by Type (2023-2028)
6 Market Size by Application
6.1 Global (-)-Trans-Caryophyllene Sales by Application
6.1.1 Global (-)-Trans-Caryophyllene Historical Sales by Application (2017-2022)
6.1.2 Global (-)-Trans-Caryophyllene Forecasted Sales by Application (2023-2028)
6.1.3 Global (-)-Trans-Caryophyllene Sales Market Share by Application (2017-2028)
6.2 Global (-)-Trans-Caryophyllene Revenue by Application
6.2.1 Global (-)-Trans-Caryophyllene Historical Revenue by Application (2017-2022)
6.2.2 Global (-)-Trans-Caryophyllene Forecasted Revenue by Application (2023-2028)
6.2.3 Global (-)-Trans-Caryophyllene Revenue Market Share by Application (2017-2028)
6.3 Global (-)-Trans-Caryophyllene Price by Application
6.3.1 Global (-)-Trans-Caryophyllene Price by Application (2017-2022)
6.3.2 Global (-)-Trans-Caryophyllene Price Forecast by Application (2023-2028)
7 North America
7.1 North America (-)-Trans-Caryophyllene Market Size by Type
7.1.1 North America (-)-Trans-Caryophyllene Sales by Type (2017-2028)
7.1.2 North America (-)-Trans-Caryophyllene Revenue by Type (2017-2028)
7.2 North America (-)-Trans-Caryophyllene Market Size by Application
7.2.1 North America (-)-Trans-Caryophyllene Sales by Application (2017-2028)
7.2.2 North America (-)-Trans-Caryophyllene Revenue by Application (2017-2028)
7.3 North America (-)-Trans-Caryophyllene Sales by Country
7.3.1 North America (-)-Trans-Caryophyllene Sales by Country (2017-2028)
7.3.2 North America (-)-Trans-Caryophyllene Revenue by Country (2017-2028)
7.3.3 United States
7.3.4 Canada
8 Europe
8.1 Europe (-)-Trans-Caryophyllene Market Size by Type
8.1.1 Europe (-)-Trans-Caryophyllene Sales by Type (2017-2028)
8.1.2 Europe (-)-Trans-Caryophyllene Revenue by Type (2017-2028)
8.2 Europe (-)-Trans-Caryophyllene Market Size by Application
8.2.1 Europe (-)-Trans-Caryophyllene Sales by Application (2017-2028)
8.2.2 Europe (-)-Trans-Caryophyllene Revenue by Application (2017-2028)
8.3 Europe (-)-Trans-Caryophyllene Sales by Country
8.3.1 Europe (-)-Trans-Caryophyllene Sales by Country (2017-2028)
8.3.2 Europe (-)-Trans-Caryophyllene Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific (-)-Trans-Caryophyllene Market Size by Type
9.1.1 Asia Pacific (-)-Trans-Caryophyllene Sales by Type (2017-2028)
9.1.2 Asia Pacific (-)-Trans-Caryophyllene Revenue by Type (2017-2028)
9.2 Asia Pacific (-)-Trans-Caryophyllene Market Size by Application
9.2.1 Asia Pacific (-)-Trans-Caryophyllene Sales by Application (2017-2028)
9.2.2 Asia Pacific (-)-Trans-Caryophyllene Revenue by Application (2017-2028)
9.3 Asia Pacific (-)-Trans-Caryophyllene Sales by Region
9.3.1 Asia Pacific (-)-Trans-Caryophyllene Sales by Region (2017-2028)
9.3.2 Asia Pacific (-)-Trans-Caryophyllene Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 China Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
10 Latin America
10.1 Latin America (-)-Trans-Caryophyllene Market Size by Type
10.1.1 Latin America (-)-Trans-Caryophyllene Sales by Type (2017-2028)
10.1.2 Latin America (-)-Trans-Caryophyllene Revenue by Type (2017-2028)
10.2 Latin America (-)-Trans-Caryophyllene Market Size by Application
10.2.1 Latin America (-)-Trans-Caryophyllene Sales by Application (2017-2028)
10.2.2 Latin America (-)-Trans-Caryophyllene Revenue by Application (2017-2028)
10.3 Latin America (-)-Trans-Caryophyllene Sales by Country
10.3.1 Latin America (-)-Trans-Caryophyllene Sales by Country (2017-2028)
10.3.2 Latin America (-)-Trans-Caryophyllene Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
10.3.6 Colombia
11 Middle East and Africa
11.1 Middle East and Africa (-)-Trans-Caryophyllene Market Size by Type
11.1.1 Middle East and Africa (-)-Trans-Caryophyllene Sales by Type (2017-2028)
11.1.2 Middle East and Africa (-)-Trans-Caryophyllene Revenue by Type (2017-2028)
11.2 Middle East and Africa (-)-Trans-Caryophyllene Market Size by Application
11.2.1 Middle East and Africa (-)-Trans-Caryophyllene Sales by Application (2017-2028)
11.2.2 Middle East and Africa (-)-Trans-Caryophyllene Revenue by Application (2017-2028)
11.3 Middle East and Africa (-)-Trans-Caryophyllene Sales by Country
11.3.1 Middle East and Africa (-)-Trans-Caryophyllene Sales by Country (2017-2028)
11.3.2 Middle East and Africa (-)-Trans-Caryophyllene Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE
12 Corporate Profiles
12.1 Sigma-Aldrich
12.1.1 Sigma-Aldrich Corporation Information
12.1.2 Sigma-Aldrich Overview
12.1.3 Sigma-Aldrich (-)-Trans-Caryophyllene Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 Sigma-Aldrich (-)-Trans-Caryophyllene Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Sigma-Aldrich Recent Developments
12.2 MP Biomedicals
12.2.1 MP Biomedicals Corporation Information
12.2.2 MP Biomedicals Overview
12.2.3 MP Biomedicals (-)-Trans-Caryophyllene Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 MP Biomedicals (-)-Trans-Caryophyllene Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 MP Biomedicals Recent Developments
12.3 Santa Cruz Biotechnology
12.3.1 Santa Cruz Biotechnology Corporation Information
12.3.2 Santa Cruz Biotechnology Overview
12.3.3 Santa Cruz Biotechnology (-)-Trans-Caryophyllene Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 Santa Cruz Biotechnology (-)-Trans-Caryophyllene Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Santa Cruz Biotechnology Recent Developments
12.4 BioCrick
12.4.1 BioCrick Corporation Information
12.4.2 BioCrick Overview
12.4.3 BioCrick (-)-Trans-Caryophyllene Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 BioCrick (-)-Trans-Caryophyllene Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 BioCrick Recent Developments
12.5 Supelco
12.5.1 Supelco Corporation Information
12.5.2 Supelco Overview
12.5.3 Supelco (-)-Trans-Caryophyllene Sales, Price, Revenue and Gross Margin (2017-2022)
12.5.4 Supelco (-)-Trans-Caryophyllene Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Supelco Recent Developments
12.6 Toronto Research Chemicals
12.6.1 Toronto Research Chemicals Corporation Information
12.6.2 Toronto Research Chemicals Overview
12.6.3 Toronto Research Chemicals (-)-Trans-Caryophyllene Sales, Price, Revenue and Gross Margin (2017-2022)
12.6.4 Toronto Research Chemicals (-)-Trans-Caryophyllene Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Toronto Research Chemicals Recent Developments
12.7 National Analytical Corporation
12.7.1 National Analytical Corporation Corporation Information
12.7.2 National Analytical Corporation Overview
12.7.3 National Analytical Corporation (-)-Trans-Caryophyllene Sales, Price, Revenue and Gross Margin (2017-2022)
12.7.4 National Analytical Corporation (-)-Trans-Caryophyllene Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 National Analytical Corporation Recent Developments
12.8 ChemFaces
12.8.1 ChemFaces Corporation Information
12.8.2 ChemFaces Overview
12.8.3 ChemFaces (-)-Trans-Caryophyllene Sales, Price, Revenue and Gross Margin (2017-2022)
12.8.4 ChemFaces (-)-Trans-Caryophyllene Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 ChemFaces Recent Developments
12.9 Extrasynthese
12.9.1 Extrasynthese Corporation Information
12.9.2 Extrasynthese Overview
12.9.3 Extrasynthese (-)-Trans-Caryophyllene Sales, Price, Revenue and Gross Margin (2017-2022)
12.9.4 Extrasynthese (-)-Trans-Caryophyllene Product Model Numbers, Pictures, Descriptions and Specifications
12.9.5 Extrasynthese Recent Developments
12.10 Purisys
12.10.1 Purisys Corporation Information
12.10.2 Purisys Overview
12.10.3 Purisys (-)-Trans-Caryophyllene Sales, Price, Revenue and Gross Margin (2017-2022)
12.10.4 Purisys (-)-Trans-Caryophyllene Product Model Numbers, Pictures, Descriptions and Specifications
12.10.5 Purisys Recent Developments
12.11 Axios
12.11.1 Axios Corporation Information
12.11.2 Axios Overview
12.11.3 Axios (-)-Trans-Caryophyllene Sales, Price, Revenue and Gross Margin (2017-2022)
12.11.4 Axios (-)-Trans-Caryophyllene Product Model Numbers, Pictures, Descriptions and Specifications
12.11.5 Axios Recent Developments
12.12 Wen Xi Pharma
12.12.1 Wen Xi Pharma Corporation Information
12.12.2 Wen Xi Pharma Overview
12.12.3 Wen Xi Pharma (-)-Trans-Caryophyllene Sales, Price, Revenue and Gross Margin (2017-2022)
12.12.4 Wen Xi Pharma (-)-Trans-Caryophyllene Product Model Numbers, Pictures, Descriptions and Specifications
12.12.5 Wen Xi Pharma Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 (-)-Trans-Caryophyllene Industry Chain Analysis
13.2 (-)-Trans-Caryophyllene Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 (-)-Trans-Caryophyllene Production Mode & Process
13.4 (-)-Trans-Caryophyllene Sales and Marketing
13.4.1 (-)-Trans-Caryophyllene Sales Channels
13.4.2 (-)-Trans-Caryophyllene Distributors
13.5 (-)-Trans-Caryophyllene Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 (-)-Trans-Caryophyllene Industry Trends
14.2 (-)-Trans-Caryophyllene Market Drivers
14.3 (-)-Trans-Caryophyllene Market Challenges
14.4 (-)-Trans-Caryophyllene Market Restraints
15 Key Finding in The Global (-)-Trans-Caryophyllene Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer